The share price of Beximco Pharma (TIDM: BXP), at least for as long as I have been invested in it (nearly 2 years) has never reached its net asset value..
yet the company is continually making a reasonable profit and issuing stock dividends. Do I question why? Not really. I still just play the price according to a short term oversold/overbought swing, but in companies which are profit-making and issuing dividends I am more inclined to keep the value of the gain in the form of shares, but each to their own. Towards the build-up of the 2011 final results saw a number of technical boxes ticked:
1. Major volume on 19 March 2012 after a bullish divergence in money flow since the start of March 2012.
2. Two slow stochastic oversold-overbought cycles between 15 March 2012 (20p) and 28 March 2012 (23.75p), and the starts of April 2012 (20.5p) and May 2012 (28p).
3. Bearish divergence (higher price highs versus lower indicator highs) with slow stochastic oscillator, money flow, and ultimate oscillator for the peaks of 2 May 2012 and 15 May 2012.
4. Hourly Coppock curve went positive from 24 April 2012 at ~23.75p.
The Writer's views are their own, not a representation of London South East's. No advice is inferred or given. If you require financial advice, please seek an Independent Financial Adviser.
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.